Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102564866 | 10256486 | 6 | F | 20130125 | 20151224 | 20140624 | 20151231 | EXP | JP-JNJFOC-20130802863 | JANSSEN | 75.32 | YR | E | F | Y | 0.00000 | 20151231 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102564866 | 10256486 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 825 | MG | N | 0 | 15 | MG | TABLET | QD | ||||
| 102564866 | 10256486 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 825 | MG | N | 0 | 10 | MG | TABLET | QD | ||||
| 102564866 | 10256486 | 3 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 825 | MG | N | 0 | 10 | MG | TABLET | QD | ||||
| 102564866 | 10256486 | 4 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 825 | MG | N | 0 | 15 | MG | TABLET | QD | ||||
| 102564866 | 10256486 | 5 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 825 | MG | N | 0 | 15 | MG | TABLET | QD | ||||
| 102564866 | 10256486 | 6 | PS | XARELTO | RIVAROXABAN | 1 | Oral | 825 | MG | N | 202439 | 10 | MG | TABLET | QD | ||||
| 102564866 | 10256486 | 7 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 0 | 2.5 | MG | TABLET | QD | |||||||
| 102564866 | 10256486 | 8 | C | MICARDIS | TELMISARTAN | 1 | Oral | 0 | 40 | MG | TABLET | QD | |||||||
| 102564866 | 10256486 | 9 | C | EPADEL | ICOSAPENT | 1 | Oral | 0 | 2 | DF | CAPSULE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 102564866 | 10256486 | 1 | Atrial fibrillation |
| 102564866 | 10256486 | 2 | Atrial fibrillation |
| 102564866 | 10256486 | 3 | Thrombosis prophylaxis |
| 102564866 | 10256486 | 4 | Thrombosis prophylaxis |
| 102564866 | 10256486 | 5 | Cerebrovascular accident prophylaxis |
| 102564866 | 10256486 | 6 | Cerebrovascular accident prophylaxis |
| 102564866 | 10256486 | 7 | Product used for unknown indication |
| 102564866 | 10256486 | 8 | Product used for unknown indication |
| 102564866 | 10256486 | 9 | Blood triglycerides increased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 102564866 | 10256486 | OT |
| 102564866 | 10256486 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 102564866 | 10256486 | Blood potassium increased | |
| 102564866 | 10256486 | Blood triglycerides increased | |
| 102564866 | 10256486 | Cellulitis | |
| 102564866 | 10256486 | Oedema peripheral | |
| 102564866 | 10256486 | Renal disorder | |
| 102564866 | 10256486 | Renal impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 102564866 | 10256486 | 1 | 20121201 | 20130124 | 0 | |
| 102564866 | 10256486 | 2 | 20130125 | 0 | ||
| 102564866 | 10256486 | 3 | 20130125 | 0 | ||
| 102564866 | 10256486 | 4 | 20121201 | 20130124 | 0 | |
| 102564866 | 10256486 | 5 | 20121201 | 20130124 | 0 | |
| 102564866 | 10256486 | 6 | 20130125 | 0 | ||
| 102564866 | 10256486 | 8 | 20140915 | 0 | ||
| 102564866 | 10256486 | 9 | 20140816 | 0 |